Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Curriu, Marta ^a   Fausther Bovendo, Hughes ^b   Pernas, María ^c   Massanella, Marta ^a   Carrillo, Jorge ^a   Cabrera, Cecilia ^a   López Galíndez, Cecilio ^c   Clotet, Bonaventura ^a,d   Debré, Patrice ^b   Vieillard, Vincent ^b   Blanco, Julià ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSERM   (France)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 41; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; VIRUS ENVELOPE PROTEIN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA FLANKING REGION; EPITOPE MAPPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; IMMUNOSTIMULATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN ISOLATION; RECEPTOR BLOCKING; VIRAL TROPISM; VIRUS IDENTIFICATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; CHEMISTRY; CYTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; TIME; VIREMIA; VIROLOGY; VIRUS ENTRY;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, HUMORAL; MOLECULAR SEQUENCE DATA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; TIME FACTORS; VIRAL TROPISM; VIREMIA; VIRUS INTERNALIZATION;

EID: 84856439561     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030330     Document Type: Article

References (38)

1. Casado C, Colombo S, Rauch A, Martínez R, Günthard HF, et al. (2010) Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5: e11079.
2. Dalmau J, Puertas MC, Azuara M, Mariño A, Frahm N, et al. (2009) Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. Clin Infect Dis 48: 229-238.
3. Gandhi RT, Chen BK, Straus SE, Dale JK, Lenardo MJ, Baltimore D, (1998) HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med 187: 1113-1122.
4. McCune JM, (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974-979.
5. Badley AD, Pilon AA, Landay A, Lynch DH, (2000) Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96: 2951-2964.
6. Gougeon ML, Piacentini M, (2009) New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14: 501-508.
7. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, et al. (2010) Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143: 789-801.
8. Blanco J, Barretina J, Cabrera C, Gutiérrez A, Clotet B, Esté JA, (2001) CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro. Virology 285: 356-365.
9. Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, et al. (1989) Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1: 983-985.
10. Etemad-Moghadam B, Rhone D, Steenbeke T, Sun Y, Manola J, et al. (2001) Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simianhuman immunodeficiency virus. J Virol 75: 5646-5655.
11. Karlsson GB, Halloran M, Schenten D, Lee J, Racz P, et al. (1998) The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med 188: 1159-1171.
12. LaBonte JA, Patel T, Hofmann W, Sodroski J, (2000) Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J Virol 74: 10690-10698.
13. Blanco J, Barretina J, Ferri KF, Jacotot E, Gutiérrez A, et al. (2003) Cell-surfaceexpressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. Virology 305: 318-329.
14. Blanco J, Barretina J, Clotet B, Esté JA, (2004) R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. J Leukoc Biol 76: 804-811.
15. Denizot M, Varbanov M, Espert L, Robert-Hebmann V, Sagnier S, et al. (2008) HIV- 1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 4: 998-1008.
16. Paiardini M, Pandrea I, Apetrei C, Silvestri G, (2009) Lessons learned from the natural hosts of HIV-related viruses. Annu Rev Med 60: 485-495.
17. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger S, et al. (2011) Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest.
18. Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, et al. (2007) Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 81: 8838-8842.
19. Vieillard V, Fausther-Bovendo H, Samri A, Debré P, French Asymptomatiques à Long Terme (ALT) ANRS-CO15 Study Group (2010) Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr 53: 564-573.
20. Vieillard V, Strominger JL, Debré P, (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 102: 10981-10986.
21. Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debré P, (2010) HIV gp41 Engages gC1qR on CD4+ T Cells to Induce the Expression of an NK Ligand through the PIP3/H2O2 Pathway. PLoS Pathog 6: e1000975.
22. Vieillard V, Costagliola D, Simon A, Debré P, French Asymptomatiques à Long Terme (ALT) Study Group (2006) Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection. AIDS 20: 1795-1804.
23. Vieillard V, Habib RE, Brochard P, Delache B, Bovendo HF, et al. (2008) CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques. AIDS 22: 185-192.
24. Vieillard V, Le Grand R, Dausset J, Debré P, (2008) A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques. Proc Natl Acad Sci U S A 105: 2100-2104.
25. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, et al. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79: 10108-10125.
26. Li Y, Svehla K, Mathy NL, Voss G, Mascola JR, Wyatt R, (2006) Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol 80: 1414-1426.
27. Malim MH, Hauber J, Fenrick R, Cullen BR, (1988) Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335: 181-183.
28. Freed EO, Myers DJ, Risser R, (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci U S A 87: 4650-4654.
29. Jensen MA, Coetzer M, van 't Wout AB, Morris L, Mullins JI, (2006) A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 80: 4698-4704.
30. Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, et al. (2007) Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 12: 1097-1106.
31. Sterjovski J, Churchill MJ, Ellett A, Gray LR, Roche MJ, et al. (2007) Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology 4: 89.
32. Blanco J, Canela EI, Mallol J, Lluís C, Franco R, (1992) Characterization of adenosine receptors in brush-border membranes from pig kidney. Br J Pharmacol 107: 671-678.
33. Garg H, Joshi A, Freed EO, Blumenthal R, (2007) Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem 282: 16899-16906.
34. Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, et al. (2009) Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog 5: e1000377.
35. Doria-Rose NA, Klein RM, Daniels MG, O'Dell S, Nason M, et al. (2010) Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J Virol 84: 1631-1636.
36. Euler Z, van Gils MJ, Bunnik EM, Phung P, Schweighardt B, et al. (2010) Crossreactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J Infect Dis 201: 1045-1053.
37. Pietzsch J, Scheid JF, Mouquet H, Seaman MS, Broder CC, Nussenzweig MC, (2010) Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity. J Virol 84: 5032-5042.
38. Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, et al. (2003) Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 111: 1547-1554.